Status:
ACTIVE_NOT_RECRUITING
RSYR for Fatigue Reduction in Cancer Fatigue Caused by Chemotherapy
Lead Sponsor:
Peking University Cancer Hospital & Institute
Conditions:
Cancer-related Problem/Condition
Eligibility:
All Genders
18-70 years
Phase:
PHASE2
Brief Summary
This is a multicenter, randomized, double-blind clinical trial to evaluate the efficacy and safety of Chinese herbal compound in improving fatigue symptoms and quality of life in patients with chemoth...
Detailed Description
In this study, symptomatic indicators and quality of life were used as the main evaluation indicators. Patients with moderate to severe CRF who received dual drug chemotherapy were given traditional C...
Eligibility Criteria
Inclusion
- Malignant tumor patients with pathological diagnosis
- Men and women aged 18-75
- KPS score ≥ 70, expected survival time more than 6 months
- The function of heart, lung, liver and kidney was normal
- Hemoglobin ≥ 8g
- Neuroendocrine function is normal
- BMI ≥ 18.5.
- Cancer pain, VAS score \< 3
- Fatigue score ≥ 4
- syndrome differentiation is deficiency of Qi and blood
Exclusion
- Brain metastases with Symptomatic
- Mental disease
- Severe infection
- Insomniacs
- Pregnant or lactating women
Key Trial Info
Start Date :
April 2 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2024
Estimated Enrollment :
196 Patients enrolled
Trial Details
Trial ID
NCT05229029
Start Date
April 2 2020
End Date
June 30 2024
Last Update
January 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Cancer Hospital
Beijing, Beijing Municipality, China, 100142